Acquired von Willebrand disease in children undergoing extracorporeal membrane oxygenation: a prospective

Joppe G Drop1, Enno D Wildschut2, Moniek P M de Maat3

  • 1Department of Paediatrics, Division of Paediatric Hematology, Erasmus Medical Center Rotterdam - Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Paediatrics, Division of Pediatric Intensive care and Pediatric surgery, Erasmus Medical Center Rotterdam - Sophia Children's Hospital, Rotterdam, the Netherlands.

Insights

Children on extracorporeal membrane oxygenation (ECMO) frequently develop acquired von Willebrand disease (AVWD). This condition develops quickly after ECMO initiation and resolves upon cessation, but it does not appear to cause major bleeding complications.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Cardiopulmonary support

Background:

  • Extracorporeal membrane oxygenation (ECMO) is vital for pediatric patients with severe cardiac or pulmonary failure.
  • Bleeding complications are frequent during ECMO support.
  • Acquired von Willebrand disease (AVWD) is a potential contributor to these bleeding issues.

Purpose of the Study:

  • To determine the incidence and temporal changes of AVWD in children during the first 14 days of ECMO.
  • To assess the relationship between AVWD and bleeding complications in this population.

Main Methods:

  • Prospective observational study of pediatric patients (0-17 years) on ECMO.
  • Serial blood sampling to analyze von Willebrand factor (VWF) parameters and multimer patterns.
  • AVWD defined by loss of high-molecular weight multimers or specific VWF ratio thresholds.

Main Results:

  • All 50 patients developed AVWD during ECMO.
  • VWF parameters and high-molecular weight multimers decreased early in ECMO and normalized within 24 hours of cessation.
  • AVWD incidence and profile were similar in patients with and without major bleeding.

Conclusions:

  • Pediatric patients on ECMO commonly develop AVWD.
  • AVWD onset is rapid post-ECMO initiation and resolution is quick after ECMO cessation.
  • AVWD appears to be an independent finding and not directly linked to major bleeding events.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
163
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
991
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
272
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
245